Former Pfizer CEO Kindler Named To Presidential Board On Government "Best Practices"
This article was originally published in The Pink Sheet Daily
Jeffrey Kindler will bring the big pharma perspective to the newly-constituted President's Management Advisory Board.
You may also be interested in...
People In The News: Tracking The Latest Industry Personnel Moves
Don Berwick steps down as CMS chief; new leadership at BIO Ventures for Global Health; former Pfizer CEO Kindler joins two boards of directors; more personnel announcements in this month’s column.
Pfizer Turns To Insider Ian Read To See It Into Post-Lipitor Era
The 32-year Pfizer veteran will take over for Jeffrey Kindler in a succession viewed as a surprise by Wall Street.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.